MediLynx Cardiac Monitoring Awarded Patent for Remote ECG Monitoring With Full Disclosure ECG Signal Transmission
PLANO, Texas, May 16, 2019 /PRNewswire/ --MediLynx Cardiac Monitoring LLC today announced the company has received a patent for its PocketECG full-disclosure ECG monitoring and transmission technology with patient symptomatic event reporting for remote cardiac monitoring.
- PLANO, Texas, May 16, 2019 /PRNewswire/ --MediLynx Cardiac Monitoring LLC today announced the company has received a patent for its PocketECG full-disclosure ECG monitoring and transmission technology with patient symptomatic event reporting for remote cardiac monitoring.
- The patent covers use of the technology and methodology for arrhythmia monitoring and for remote or home-based cardiac rehabilitation.
- The PocketECG integrated arrhythmia monitoring system is cleared by the Food and Drug Administration for ambulatory cardiac monitoring.
- MediLynx Cardiac Monitoring LLC, is a leader in cardiac monitoring, delivering best-in-class cardiac diagnostic solutions and service to enable the best possible care for patients.